Six critically ill Israeli coronavirus patients with organ failure are still alive after 1-week’s Pluristem’s PLX cell-therapy in three separate Israeli medical centers. Four show improved respiratory parameters – three of those could soon be weaned off ventilators with two showing clinical recovery.
- Latest – The first critically ill US coronavirus patient has received Pluristem’s treatment (in New Jersey).